ArticleGenes & diseases2024

Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration.

Xinzhu Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.